http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26929453

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 52
issn 1179-5549
pageRange CMO.S7999-52
publicationName Clinical Medicine Insights: Oncology
startingPage CMO.S7999
bibliographicCitation Degrauwe N, Sosa JA, Roman S, Deshpande HA. Vandetanib for the treatment of metastatic medullary thyroid cancer. Clin Med Insights Oncol. 2012;6():243–52. PMID: 22723734; PMCID: PMC3379848.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39e55c833f3a0971278b7873b746be55
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43b673dede4bf377e0c1e49273313019
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cef000b1849449bffce35ff8ad63918
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58fa7f5b3122642ee1e6509e354edc1e
date 201201
identifier https://doi.org/10.4137/cmo.s7999
https://pubmed.ncbi.nlm.nih.gov/PMC3379848
https://pubmed.ncbi.nlm.nih.gov/22723734
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37328
https://portal.issn.org/resource/ISSN/1179-5549
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID1544
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID1542
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8615
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2cb9df9898e55fd0ad829dc202ddbd1c

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 30.